\-\ Texto\\:\\ \ \(0\)\
\-\ mri\\ shows\\ an\\ extra\\ axial\\ lobulated\\ mass\\ located\\ at\\ the\\ floor\\ of\\ the\\ anterior\\ cranial\\ fossa\\ bilaterally\\,\\ and\\ lateral\\ to\\ the\\ right\\ frontal\\ lobe\\,\\ with\\ t1\\ intermediate\\ signal\\ and\\ t2\\ low\\ signal\\.\\ \\ it\\ enhances\\ with\\ some\\ internal\\ heterogeneity\\.\\ \\ associated\\ reactive\\ edema\\.\\ \\ cxr\\ by\\ report\\ was\\ normal\\.\ \(0\)\
\-\ neurosarcoid\ \(5\)\
\-\ neurosarcoid\\.\ \(1\)\
\-\ meningitis\\ \\(particularly\\ tb\\ or\\ fungal\\)\\.\ \(0\)\
\-\ epidural\\ infection\\ \\(extension\\ from\\ adjacent\\ sinus\\ disease\\.\\)\ \(0\)\
\-\ meningioma\\.\ \(27\)\
\-\ metastatic\\ disease\\.\ \(69\)\
\-\ 49\\ yo\\ man\\,\\ history\\ of\\ sarcoidosis\\,\\ with\\ seizures\\.\ \(1\)\
\-\ about\\ 5\\%\\ of\\ patients\\ with\\ sarcoid\\ have\\ clinical\\ cns\\ involvement\\.\\ \\ 27\\%\\ have\\ cns\\ involvement\\ at\\ autopsy\\.\\ \\ \\>90\\%\\ of\\ neurosarcoid\\ cases\\ will\\ have\\ involvement\\ of\\ the\\ lungs\\.\\ \\ most\\ cns\\ cases\\ present\\ with\\ cranial\\ nerve\\ deficits\\,\\ most\\ often\\ facial\\ nerve\\ \\(cn\\ vii\\)\\ palsy\\.\\ \\ clinical\\ and\\ imaging\\ findings\\ are\\ often\\ disparate\\.\\ \\ clinical\\ course\\ is\\ usually\\ a\\ self\\ limted\\ monophasic\\ illness\\.\\ \\ most\\ respond\\ to\\ steroids\\.\\ \\ imaging\\ resolution\\ lags\\ clinical\\ symptom\\ resolution\\.\ \(0\)\
\-\ in\\ this\\ case\\,\\ mri\\ shows\\ isointense\\ dural\\-based\\ lesions\\ on\\ t1\\,\\ that\\ are\\ hypointense\\ on\\ t2\\,\\ with\\ variable\\ enhancement\\.\ \(0\)\
\-\ ref\\:\\ a\\ osborn\\,\\ et\\ al\\,\\ diagnositic\\ imaging\\ of\\ the\\ brain\\,\\ 2004\\;\\ ii\\:4\\-55i\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ neurosarcoid\\:\\ 0\\.09454705495186111\ \(0\)\
\-\ cns\\:\\ 0\\.062469530963945454\ \(0\)\
\-\ clinical\\:\\ 0\\.050082091429828654\ \(0\)\
\-\ involvement\\:\\ 0\\.0447419808089688\ \(0\)\
\-\ limted\\:\\ 0\\.04197865916174524\ \(0\)\
\-\ lags\\:\\ 0\\.04197865916174524\ \(0\)\
\-\ ii\\:4\\-55i\\:\\ 0\\.04197865916174524\ \(0\)\
\-\ disparate\\:\\ 0\\.03867795830193597\ \(0\)\
\-\ dural\\-based\\:\\ 0\\.03674717207284947\ \(0\)\
\-\ cranial\\:\\ 0\\.035387161868021905\ \(0\)\
\-\ resolution\\:\\ 0\\.03510114008612786\ \(0\)\
\-\ monophasic\\:\\ 0\\.03344647121304021\ \(0\)\
\-\ diagnositic\\:\\ 0\\.03344647121304021\ \(0\)\
\-\ osborn\\:\\ 0\\.03151568498395371\ \(0\)\
\-\ heterogeneity\\:\\ 0\\.029411719496910668\ \(0\)\
\-\ nerve\\:\\ 0\\.029323296442736253\ \(0\)\
\-\ autopsy\\:\\ 0\\.028775855722508178\ \(0\)\
\-\ vii\\:\\ 0\\.028775855722508178\ \(0\)\
\-\ ref\\:\\ 0\\.028775855722508178\ \(0\)\
\-\ imaging\\:\\ 0\\.028601054635080038\ \(0\)\
\-\ \\%\\:\\ 0\\.028476014762085822\ \(0\)\
\-\ most\\:\\ 0\\.028183359167543942\ \(0\)\
\-\ self\\:\\ 0\\.02725940938384849\ \(0\)\
\-\ cases\\:\\ 0\\.02711248441886793\ \(0\)\
\-\ respond\\:\\ 0\\.027047734323987375\ \(0\)\
\-\ have\\:\\ 0\\.026434829690929883\ \(0\)\
\-\ often\\:\\ 0\\.025966414747806213\ \(0\)\
\-\ t1\\:\\ 0\\.02579519558308804\ \(0\)\
\-\ extra\\:\\ 0\\.025475154862698912\ \(0\)\
\-\ intermediate\\:\\ 0\\.023446181551694627\ \(0\)\
\-\ symptom\\:\\ 0\\.023072507192449417\ \(0\)\
\-\ t2\\:\\ 0\\.023034178750003353\ \(0\)\
\-\ floor\\:\\ 0\\.02289612018444775\ \(0\)\
\-\ illness\\:\\ 0\\.022643216254381333\ \(0\)\
\-\ 49\\:\\ 0\\.022561814190765615\ \(0\)\
\-\ palsy\\:\\ 0\\.022561814190765615\ \(0\)\
\-\ shows\\:\\ 0\\.022374987616465513\ \(0\)\
\-\ cn\\:\\ 0\\.021885765327573293\ \(0\)\
\-\ 2004\\:\\ 0\\.021885765327573293\ \(0\)\
\-\ variable\\:\\ 0\\.021680183556786588\ \(0\)\
\-\ signal\\:\\ 0\\.021457850764502656\ \(0\)\
\-\ meningitis\\:\\ 0\\.021111865663298174\ \(0\)\
\-\ particularly\\:\\ 0\\.020994281793820214\ \(0\)\
\-\ sarcoid\\:\\ 0\\.02087953154820564\ \(0\)\
\-\ lobulated\\:\\ 0\\.020446332604368848\ \(0\)\
\-\ epidural\\:\\ 0\\.0200492773237067\ \(0\)\
\-\ isointense\\:\\ 0\\.02000189479583447\ \(0\)\
\-\ fungal\\:\\ 0\\.0197270932833552\ \(0\)\
\-\ tb\\:\\ 0\\.019595419324638486\ \(0\)\
\-\ hypointense\\:\\ 0\\.01930164042461306\ \(0\)\
\-\ reactive\\:\\ 0\\.01926111333095635\ \(0\)\
\-\ enhances\\:\\ 0\\.019220928242166518\ \(0\)\
\-\ 90\\:\\ 0\\.01918107943421168\ \(0\)\
\-\ steroids\\:\\ 0\\.019141561325570274\ \(0\)\
\-\ 27\\:\\ 0\\.018873753143080388\ \(0\)\
\-\ mri\\:\\ 0\\.018697865284901142\ \(0\)\
\-\ deficits\\:\\ 0\\.018620207835847946\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.018379482696977322\ \(0\)\
\-\ report\\:\\ 0\\.01821469446279887\ \(0\)\
\-\ facial\\:\\ 0\\.017693580934010952\ \(0\)\
\-\ seizures\\:\\ 0\\.017494546987923038\ \(0\)\
\-\ al\\:\\ 0\\.01725029320512518\ \(0\)\
\-\ cxr\\:\\ 0\\.017171582243452752\ \(0\)\
\-\ located\\:\\ 0\\.01674857646389744\ \(0\)\
\-\ et\\:\\ 0\\.016654278238677534\ \(0\)\
\-\ fossa\\:\\ 0\\.016584760146195855\ \(0\)\
\-\ about\\:\\ 0\\.015685988124305963\ \(0\)\
\-\ meningioma\\:\\ 0\\.01564804445930988\ \(0\)\
\-\ lungs\\:\\ 0\\.015408517133239411\ \(0\)\
\-\ course\\:\\ 0\\.015354911635503055\ \(0\)\
\-\ sinus\\:\\ 0\\.014881709379249704\ \(0\)\
\-\ extension\\:\\ 0\\.014525368196103113\ \(0\)\
\-\ \\,\\:\\ 0\\.01418005105090553\ \(0\)\
\-\ internal\\:\\ 0\\.013642266054184627\ \(0\)\
\-\ \\>\\:\\ 0\\.013519845307945547\ \(0\)\
\-\ bilaterally\\:\\ 0\\.013365263040590016\ \(0\)\
\-\ disease\\:\\ 0\\.013302262297292422\ \(0\)\
\-\ adjacent\\:\\ 0\\.012865886876829845\ \(0\)\
\-\ frontal\\:\\ 0\\.012782342545158846\ \(0\)\
\-\ will\\:\\ 0\\.01273086199228163\ \(0\)\
\-\ some\\:\\ 0\\.01235680120888933\ \(0\)\
\-\ usually\\:\\ 0\\.01235680120888933\ \(0\)\
\-\ yo\\:\\ 0\\.012244531063346487\ \(0\)\
\-\ brain\\:\\ 0\\.012244531063346487\ \(0\)\
\-\ 5\\:\\ 0\\.011905525821162683\ \(0\)\
\-\ infection\\:\\ 0\\.011828650352727654\ \(0\)\
\-\ axial\\:\\ 0\\.011613292743180341\ \(0\)\
\-\ edema\\:\\ 0\\.011509159473482338\ \(0\)\
\-\ low\\:\\ 0\\.011315085966030475\ \(0\)\
\-\ are\\:\\ 0\\.011094036881234302\ \(0\)\
\-\ at\\:\\ 0\\.011026315741253649\ \(0\)\
\-\ lobe\\:\\ 0\\.010949168323445401\ \(0\)\
\-\ enhancement\\:\\ 0\\.010907089362490649\ \(0\)\
\-\ lesions\\:\\ 0\\.010893145268304514\ \(0\)\
\-\ patients\\:\\ 0\\.010531307616028695\ \(0\)\
\-\ anterior\\:\\ 0\\.010479965827441607\ \(0\)\
\-\ \\(\\:\\ 0\\.01031945323205515\ \(0\)\
\-\ metastatic\\:\\ 0\\.010243378112457574\ \(0\)\
\-\ \\)\\:\\ 0\\.010193395601618643\ \(0\)\
\-\ \\;\\:\\ 0\\.00964486280215521\ \(0\)\
\-\ man\\:\\ 0\\.009623484967095235\ \(0\)\
\-\ associated\\:\\ 0\\.009602202675750963\ \(0\)\
\-\ present\\:\\ 0\\.009190517875865148\ \(0\)\
\-\ it\\:\\ 0\\.009146897069204843\ \(0\)\
\-\ case\\:\\ 0\\.008902402061272718\ \(0\)\
\-\ lateral\\:\\ 0\\.008793657360116907\ \(0\)\
\-\ findings\\:\\ 0\\.008661128265666476\ \(0\)\
\-\ that\\:\\ 0\\.007028479659803921\ \(0\)\
\-\ on\\:\\ 0\\.006894200117765982\ \(0\)\
\-\ by\\:\\ 0\\.006775575729737499\ \(0\)\
\-\ normal\\:\\ 0\\.006379106926662386\ \(0\)\
\-\ from\\:\\ 0\\.006030646253115298\ \(0\)\
\-\ mass\\:\\ 0\\.005659338128321736\ \(0\)\
\-\ an\\:\\ 0\\.0056269755442129995\ \(0\)\
\-\ history\\:\\ 0\\.005620069227176588\ \(0\)\
\-\ \\:\\:\\ 0\\.005382261028526977\ \(0\)\
\-\ or\\:\\ 0\\.004769155947446227\ \(0\)\
\-\ was\\:\\ 0\\.0047060834391127945\ \(0\)\
\-\ this\\:\\ 0\\.004576843872924443\ \(0\)\
\-\ right\\:\\ 0\\.004293484329097223\ \(0\)\
\-\ to\\:\\ 0\\.004067315318504632\ \(0\)\
\-\ a\\:\\ 0\\.003777140969700965\ \(0\)\
\-\ with\\:\\ 0\\.003342976459711135\ \(0\)\
\-\ of\\:\\ 0\\.0033286800227996694\ \(0\)\
\-\ the\\:\\ 0\\.003291649635800614\ \(0\)\
\-\ \\.\\:\\ 0\\.003211862789759901\ \(0\)\
\-\ is\\:\\ 0\\.0026775751351653604\ \(0\)\
\-\ and\\:\\ 0\\.002571557224745978\ \(0\)\
\-\ in\\:\\ 0\\.002006653476858357\ \(0\)\
